Cargando…
High Contrast and Resolution Labeling of Amyloid Plaques in Tissue Sections from APP-PS1 Mice and Humans with Alzheimer’s Disease with the Zinc Chelator HQ-O: Practical and Theoretical Considerations
BACKGROUND: Various methodologies have been employed for the localization of amyloid plaques in numerous studies on Alzheimer’s disease. The majority of these stains are thought to label the plaques by virtue of their affinity for aggregated Aβ. However, plaques are known to contain numerous other c...
Autores principales: | Schmued, Larry, Raymick, James, Sarkar, Sumit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6807259/ https://www.ncbi.nlm.nih.gov/pubmed/31345150 http://dx.doi.org/10.2174/1567205016666190725155038 |
Ejemplares similares
-
The Use of Recently Developed Histochemical Markers for Localizing Neurotoxicant Induced Regional Brain Pathologies
por: Sarkar, Sumit, et al.
Publicado: (2014) -
Agomelatine Prevents Amyloid Plaque Deposition, Tau Phosphorylation, and Neuroinflammation in APP/PS1 Mice
por: Yang, Xiao-bo, et al.
Publicado: (2022) -
Optimization study of 2-hydroxyquinoxaline (2-HQ) biodegradation by Ochrobactrum sp. HQ1
por: Subba Reddy, G. V., et al.
Publicado: (2016) -
Memory deficiency, cerebral amyloid angiopathy, and amyloid-β plaques in APP+PS1 double transgenic rat model of Alzheimer’s disease
por: Klakotskaia, Diana, et al.
Publicado: (2018) -
Metformin attenuates plaque-associated tau pathology and reduces amyloid-β burden in APP/PS1 mice
por: Chen, Yanxing, et al.
Publicado: (2021)